Corrigendum to "The -172 A-to-G variation in ADAM17 gene promoter region affects EGR1/ADAM17 pathway and confers susceptibility to septic mortality with sepsis-3.0 criteria" [Int. Immunopharmacol. 102 (2022) 108385].